120 related articles for article (PubMed ID: 727726)
1. Juvenile parkinsonism: a patient with possible primary striatal dysfunction.
Naidu S; Wolfson LI; Sharpless NS
Ann Neurol; 1978 May; 3(5):453-5. PubMed ID: 727726
[TBL] [Abstract][Full Text] [Related]
2. 14C-homovanillic acid in the cerebrospinal fluid of parkinsonian patients after intravenous 14C-L-dopa.
Extein I; Van Woert M; Roth RH; Bowers MB
Biol Psychiatry; 1976 Apr; 11(2):227-32. PubMed ID: 971447
[TBL] [Abstract][Full Text] [Related]
3. Sydenham's chorea: a possible presynaptic dopaminergic dysfunction initially.
Naidu S; Narasimhachari N
Ann Neurol; 1980 Oct; 8(4):445-7. PubMed ID: 6159821
[TBL] [Abstract][Full Text] [Related]
4. Biochemical aids in the diagnosis of Parkinson's disease.
Chase TN; Eng N; Gordon EK
Ann Clin Lab Sci; 1976; 6(1):4-10. PubMed ID: 1247283
[TBL] [Abstract][Full Text] [Related]
5. Cerebrospinal fluid homovanillic acid levels in rapid-onset dystonia-parkinsonism.
Brashear A; Butler IJ; Hyland K; Farlow MR; Dobyns WB
Ann Neurol; 1998 Apr; 43(4):521-6. PubMed ID: 9546335
[TBL] [Abstract][Full Text] [Related]
6. Biogenic amine disturbances in cerebrospinal fluid in parkinsonism and unipolar depression: use of the probenecid method.
Vanderheyden JE; Noel G; Mendlewicz J
Neuropsychobiology; 1981; 7(3):137-51. PubMed ID: 6164951
[TBL] [Abstract][Full Text] [Related]
7. [HVA and 5-HIAA in the cerebrospinal fluid in extrapyramidal and cerebrellar syndromes. Preliminary data].
Carrieri P; Mandarini A; Campanella G
Acta Neurol (Napoli); 1975; 30(5):449-54. PubMed ID: 132845
[No Abstract] [Full Text] [Related]
8. Cerebrospinal homovanillic acid and parkinsonism.
Miachon S; Dalmaz Y; Cottet-Emard JM; Peyrin L
Biomedicine; 1974 Jul; 21(7):303-8. PubMed ID: 4433665
[No Abstract] [Full Text] [Related]
9. Biochemical investigations in Parkinsonism. A study of the metabolites of the biogenic amines in the lumbar CSF.
Pullar IA; Dowson JH; Ahmed R; Chow R; Gillingham FJ
Confin Neurol; 1972; 34(2):143-8. PubMed ID: 4666057
[No Abstract] [Full Text] [Related]
10. Parkinson's disease and amine metabolites in cerebrospinal fluid: implications for L-Dopa therapy.
Korf J; van Praag HM; Schut D; Nienhuis RJ; Lakke JP
Eur Neurol; 1974; 12(5-6):340-50. PubMed ID: 4448192
[No Abstract] [Full Text] [Related]
11. Analysis of neurotransmitter metabolites and adenosine 3',5'-monophosphate in the CSF of patients with extrapyramidal motor disorders.
Cramer H; Warter JM; Renaud B
Adv Neurol; 1984; 40():431-5. PubMed ID: 6198888
[No Abstract] [Full Text] [Related]
12. Homovanillic acid in the cerebrospinal fluid of Parkinsonian patients.
Cunha L; Gonçalves AF; Oliveira C; Dinis M; Amaral R
Can J Neurol Sci; 1983 Feb; 10(1):43-6. PubMed ID: 6839227
[No Abstract] [Full Text] [Related]
13. [Values of serial determinations of cerebrospinal fluid metabolites of biogenic amines in various neurologic diseases].
Spissu A; Piccardi MP; Corsini GU; Mangoni A
Acta Neurol (Napoli); 1976; 31(5):549-57. PubMed ID: 827925
[No Abstract] [Full Text] [Related]
14. [Homovanillic acid (HVA) and 5-hydroxyindoleacetic acid (5-HIAA) levels in the lumbar cerebrospinal fluid in epileptic patients].
Livrea P; Di Reda L; Puca FM; Genco S; Specchio L; Papagno G
Boll Soc Ital Biol Sper; 1976 Jun; 52(11):800-5. PubMed ID: 1016632
[No Abstract] [Full Text] [Related]
15. Acid monoamine metabolites in the cerebrospinal fluid of Parkinsonian patients treated with levodopa alone or combined with a decarboxylase inhibitor.
Rinne UK; Sonninen V; Siirtola T
Eur Neurol; 1973; 9(6):349-62. PubMed ID: 4712542
[No Abstract] [Full Text] [Related]
16. Clinical significance of probenecid test.
Lakke JP; Korf J; van Praag HM; Minderhoud JM; Schut T
Lancet; 1973 Mar; 1(7803):614-5. PubMed ID: 4120687
[No Abstract] [Full Text] [Related]
17. Variable phenotype of rapid-onset dystonia-parkinsonism.
Brashear A; Farlow MR; Butler IJ; Kasarskis EJ; Dobyns WB
Mov Disord; 1996 Mar; 11(2):151-6. PubMed ID: 8684384
[TBL] [Abstract][Full Text] [Related]
18. Homovanillic acid and 5-hydroxyindoleacetic acid in lumbar cerebrospinal fluid of patients with acute cerebrovascular lesion.
Livrea P; Papagno G; Di Reda L; Centrone G
Acta Neurol (Napoli); 1976; 31(5):647-51. PubMed ID: 1015387
[No Abstract] [Full Text] [Related]
19. Concentrations of 5-hydroxyindoleacetic acid and homovanillic acid in the cerebrospinal fluid after treatment with probenecid in patients with Parkinson's disease.
Olsson R; Roos BE
Nature; 1968 Aug; 219(5153):502-3. PubMed ID: 5668438
[No Abstract] [Full Text] [Related]
20. [Central metabolism of dopamine and serotonin. III. Preliminary findings on the relations between dopamine metabolism and purine metabolism in the nervous system].
Campanella G; Orefice G; Carrieri P; Mandarini A; Buscaino GA
Acta Neurol (Napoli); 1976; 31(5):571-9. PubMed ID: 138341
[No Abstract] [Full Text] [Related]
[Next] [New Search]
